Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Anti-EGFR Immunoliposomes in Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland Identifier:
First received: October 1, 2012
Last updated: September 8, 2014
Last verified: September 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2010
  Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):